{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:22:25Z","timestamp":1789521745866,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35352-5","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:24:32Z","timestamp":1767885872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u200b\u200bRubiadin-1-methyl ether alleviates bleomycin induced pulmonary fibrosis\u200b"],"prefix":"10.1038","volume":"16","author":[{"given":"Xu","family":"Zhen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Xinpeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yuhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Mengjia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Yanjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yongchun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"35352_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s40001-025-02623-2","volume":"30","author":"L Song","year":"2025","unstructured":"Song, L., Gao, F. & Man, J. Ferroptosis: the potential key roles in idiopathic pulmonary fibrosis. Eur. J. Med. Res. 30, 341 (2025).","journal-title":"Eur. J. Med. Res."},{"key":"35352_CR2","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41419-020-03178-2","volume":"11","author":"L Peng","year":"2020","unstructured":"Peng, L. et al. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death Dis. 11, 978 (2020).","journal-title":"Cell Death Dis."},{"key":"35352_CR3","doi-asserted-by":"publisher","first-page":"175346662513231","DOI":"10.1177\/17534666251323181","volume":"19","author":"JE Gross","year":"2025","unstructured":"Gross, J. E., Jones, M. C., Buige, A., Prevots, D. R. & Kasperbauer, S. Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis. Ther. Adv. Respir. Dis. 19, 17534666251323181 (2025).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"35352_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12931-022-01998-8","volume":"23","author":"L Liang","year":"2022","unstructured":"Liang, L. et al. Air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in beijing: a time-series study. Respir. Res. 23, 81 (2022).","journal-title":"Respir. Res."},{"key":"35352_CR5","unstructured":"Chin, D. et al. Genome-wide association study of idiopathic pulmonary fibrosis susceptibility using clinically-curated European-ancestry datasets. MedRxiv: Preprint Serv. Health Sciences, (2025)."},{"key":"35352_CR6","doi-asserted-by":"crossref","unstructured":"He, A., He, L., Chen, T., Li, X. & Cao, C. Biomechanical properties and cellular responses in pulmonary fibrosis. Bioengineering (Basel Switzerland) 11, (2024).","DOI":"10.3390\/bioengineering11080747"},{"key":"35352_CR7","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Therapeutic potential of Qingfeiyin Decoction in idiopathic pulmonary fibrosis: role of lung-distributed components and PI3K-AKT pathway modulation. Journal Ethnopharmacology, 120071 (2025).","DOI":"10.1016\/j.jep.2025.120071"},{"key":"35352_CR8","doi-asserted-by":"publisher","first-page":"1582860","DOI":"10.3389\/fpubh.2025.1582860","volume":"13","author":"Z Wan","year":"2025","unstructured":"Wan, Z. et al. TRAF2 regulates the progression of pulmonary fibrosis through \u03b2-catenin-Snail signaling pathway. Front. public. Health. 13, 1582860 (2025).","journal-title":"Front. public. Health"},{"key":"35352_CR9","doi-asserted-by":"crossref","unstructured":"Xiang, G. et al. Suppression of NOX2-Derived Reactive Oxygen Species (ROS) Reduces Epithelial-to-MesEnchymal Transition Through Blocking SiO(2)-Regulated JNK Activation. Toxics 13, (2025).","DOI":"10.3390\/toxics13050365"},{"key":"35352_CR10","doi-asserted-by":"crossref","unstructured":"P\u0131nar, P. et al. The relationship between chest wall muscle Thickness, pulmonary Function, and prognostic markers in idiopathic pulmonary fibrosis. Medicina (Kaunas) 61, (2025).","DOI":"10.3390\/medicina61071181"},{"key":"35352_CR11","first-page":"e2024047","volume":"41","author":"G Monteleone","year":"2024","unstructured":"Monteleone, G. et al. The management of Familial pulmonary fibrosis in different medical settings: where does that leave us? An Italian nationwide survey. Sarcoidosis Vasc Diffuse Lung Dis. 41, e2024047 (2024).","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"35352_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2220\/biomedres.46.83","volume":"46","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Finerenone alleviates the high glucose-induced fibrosis in HK-2 cells by inhibiting EMT via the TGF-\u03b21\/Smads signaling. Biomedical Res. (Tokyo Japan). 46, 83\u201392 (2025).","journal-title":"Biomedical Res. (Tokyo Japan)"},{"key":"35352_CR13","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1007\/s12035-018-1396-y","volume":"56","author":"LP Diniz","year":"2019","unstructured":"Diniz, L. P., Matias, I., Siqueira, M., Stipursky, J. & Gomes, F. C. A. Astrocytes and the TGF-\u03b21 pathway in the healthy and diseased brain: a Double-Edged sword. Mol. Neurobiol. 56, 4653\u20134679 (2019).","journal-title":"Mol. Neurobiol."},{"key":"35352_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10735-025-10402-w","volume":"56","author":"PK Poleboyina","year":"2025","unstructured":"Poleboyina, P. K., Pasha, A., Heena, S. K., Poleboyina, S. M. & Pawar, S. C. Evaluating TGF-\u03b21 gene expression and promoter polymorphism in cervical cancer progression. J. Mol. Histol. 56, 126 (2025).","journal-title":"J. Mol. Histol."},{"key":"35352_CR15","doi-asserted-by":"publisher","first-page":"113802","DOI":"10.1016\/j.fct.2023.113802","volume":"176","author":"Q Ren","year":"2023","unstructured":"Ren, Q., Bakker, W., de Haan, L., Rietjens, I. & Bouwmeester, H. Induction of Nrf2-EpRE-mediated gene expression by hydroxyanthraquinones present in extracts from traditional Chinese medicine and herbs. Food Chem. Toxicology: Int. J. Published Br. Industrial Biol. Res. Association. 176, 113802 (2023).","journal-title":"Food Chem. Toxicol. Int. J. Published Br. Industrial Biol. Res. Association"},{"key":"35352_CR16","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1177\/15353702231198071","volume":"248","author":"S Cai","year":"2023","unstructured":"Cai, S. et al. Rubiadin-1-methyl ether inhibits BECN1 transcription and Beclin1-dependent autophagy during osteoclastogenesis by inhibiting NF-\u03baB p65 activation. Exp. Biol. Med. (Maywood NJ). 248, 1518\u20131526 (2023).","journal-title":"Exp. Biol. Med. (Maywood NJ)"},{"key":"35352_CR17","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1080\/14786419.2011.608676","volume":"26","author":"Q Liu","year":"2012","unstructured":"Liu, Q. et al. Anthraquinones from Morinda officinalis roots enhance adipocyte differentiation in 3T3-L1 cells. Nat. Prod. Res. 26, 1750\u20131754 (2012).","journal-title":"Nat. Prod. Res."},{"key":"35352_CR18","doi-asserted-by":"crossref","unstructured":"Mohr, E. T. B. et al. Evidence that the anti-inflammatory effect of rubiadin-1-methyl ether has an immunomodulatory context. Mediators Inflamm 6474168 (2019). (2019).","DOI":"10.1155\/2019\/6474168"},{"key":"35352_CR19","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.jpha.2024.100971","volume":"14","author":"H Jiang","year":"2024","unstructured":"Jiang, H. et al. Spatially resolved metabolomics visualizes heterogeneous distribution of metabolites in lung tissue and the anti-pulmonary fibrosis effect of prismatomeris connate extract. J. Pharm. Anal. 14, 100971 (2024).","journal-title":"J. Pharm. Anal."},{"key":"35352_CR20","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1007\/s11356-025-36005-2","volume":"32","author":"AA Elsheikh","year":"2025","unstructured":"Elsheikh, A. A., Shalaby, A. M., Alabiad, M. A., Abd-Almotaleb, N. A. & Khayal, E. E. Perfluorooctanoic acid induced lung toxicity via TGF-\u03b21\/Smad pathway, crosstalk between airway hyperresponsiveness and fibrosis: withdrawal impact. Environ. Sci. Pollut. Res. Int. 32, 4989\u20135007 (2025).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"35352_CR21","doi-asserted-by":"publisher","first-page":"117285","DOI":"10.1016\/j.taap.2025.117285","volume":"498","author":"M Niu","year":"2025","unstructured":"Niu, M. et al. Tryptanthrin alleviate lung fibrosis via suppression of MAPK\/NF-\u03baB and TGF-\u03b21\/SMAD signaling pathways in vitro and in vivo. Toxicol. Appl. Pharmcol. 498, 117285 (2025).","journal-title":"Toxicol. Appl. Pharmcol."},{"key":"35352_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467\u2013470 (1988).","journal-title":"J. Clin. Pathol."},{"key":"35352_CR23","doi-asserted-by":"publisher","first-page":"1567994","DOI":"10.3389\/fimmu.2025.1567994","volume":"16","author":"M Yao","year":"2025","unstructured":"Yao, M. et al. Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities. Front. Immunol. 16, 1567994 (2025).","journal-title":"Front. Immunol."},{"key":"35352_CR24","doi-asserted-by":"crossref","unstructured":"Aspal, M. et al. Modeling the aging human lung: generation of a senescent human lung organoid culture system. bioRxiv: the preprint server for biology, (2025).","DOI":"10.1101\/2025.02.24.639173"},{"key":"35352_CR25","doi-asserted-by":"publisher","first-page":"1549277","DOI":"10.3389\/fimmu.2025.1549277","volume":"16","author":"J Bhatt","year":"2025","unstructured":"Bhatt, J., Ghigo, A. & Hirsch, E. PI3K\/Akt in IPF: untangling fibrosis and charting therapies. Front. Immunol. 16, 1549277 (2025).","journal-title":"Front. Immunol."},{"key":"35352_CR26","doi-asserted-by":"publisher","first-page":"100226","DOI":"10.1016\/j.slasd.2025.100226","volume":"32","author":"E B\u00e4ck","year":"2025","unstructured":"B\u00e4ck, E. et al. Enhancing throughput and robustness of the fibroblast to myofibroblast transition assay. SLAS Discovery: Adv. Life Sci. R D. 32, 100226 (2025).","journal-title":"SLAS Discovery: Adv. Life Sci. R D"},{"key":"35352_CR27","doi-asserted-by":"publisher","first-page":"204209862513416","DOI":"10.1177\/20420986251341645","volume":"16","author":"A Provenzani","year":"2025","unstructured":"Provenzani, A. et al. Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with Pirfenidone and nintedanib. Therapeutic Adv. Drug Saf. 16, 20420986251341645 (2025).","journal-title":"Therapeutic Adv. Drug Saf."},{"key":"35352_CR28","doi-asserted-by":"publisher","first-page":"1530697","DOI":"10.3389\/fphar.2025.1530697","volume":"16","author":"T Wang","year":"2025","unstructured":"Wang, T. et al. Post-marketing safety concerns with Pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases. Front. Pharmacol. 16, 1530697 (2025).","journal-title":"Front. Pharmacol."},{"key":"35352_CR29","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1164\/rccm.202207-1260LE","volume":"206","author":"MB Scholand","year":"2022","unstructured":"Scholand, M. B. & Wells, A. U. Comment on idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults. Am. J. Respir. Crit Care Med. 206, 1296 (2022).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"35352_CR30","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.4049\/jimmunol.1801515","volume":"203","author":"MS Kim","year":"2019","unstructured":"Kim, M. S. et al. IL-37 attenuates lung fibrosis by inducing autophagy and regulating TGF-\u03b21 production in mice. J. Immunol. 203, 2265\u20132275 (2019).","journal-title":"J. Immunol."},{"key":"35352_CR31","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1007\/s00210-024-03004-y","volume":"397","author":"SH Attia","year":"2024","unstructured":"Attia, S. H., Saadawy, S. F., El-Mahroky, S. M. & Nageeb, M. M. Alleviation of pulmonary fibrosis by the dual PPAR agonist Saroglitazar and breast milk mesenchymal stem cells via modulating TGF\u00df\/SMAD pathway. Naunyn Schmiedebergs Arch. Pharmacol. 397, 5953\u20135974 (2024).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"35352_CR32","doi-asserted-by":"crossref","unstructured":"Kuzminska, J. et al. Curcumin derivatives in medicinal chemistry: potential applications in cancer treatment. Molecules (Basel Switzerland) 29, (2024).","DOI":"10.3390\/molecules29225321"},{"key":"35352_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bioorg.2017.09.011","volume":"75","author":"BC Lin","year":"2017","unstructured":"Lin, B. C. et al. The anthraquinone Emodin inhibits the non-exported FIKK kinase from plasmodium falciparum. Bioorg. Chem. 75, 217\u2013223 (2017).","journal-title":"Bioorg. Chem."},{"key":"35352_CR34","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.3390\/molecules15107218","volume":"15","author":"CP Osman","year":"2010","unstructured":"Osman, C. P. et al. Anthraquinones with antiplasmodial activity from the roots of Rennellia elliptica Korth. Molecules (Basel Switzerland). 15, 7218\u20137226 (2010). Rubiaceae.","journal-title":"Molecules (Basel Switzerland)"},{"key":"35352_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/1574892813666171206123114","volume":"13","author":"AS Tikhomirov","year":"2018","unstructured":"Tikhomirov, A. S., Shtil, A. A. & Shchekotikhin, A. E. Advances in the discovery of anthraquinone-based anticancer agents. Recent Pat. Anti-cancer Drug Discov. 13, 159\u2013183 (2018).","journal-title":"Recent Pat. Anti-cancer Drug Discov."},{"key":"35352_CR36","doi-asserted-by":"crossref","unstructured":"Yusuf, M. A. et al. Chrysophanol: a natural anthraquinone with multifaceted biotherapeutic potential. Biomolecules 9, (2019).","DOI":"10.3390\/biom9020068"},{"key":"35352_CR37","doi-asserted-by":"publisher","first-page":"6864","DOI":"10.1016\/j.bmcl.2013.09.098","volume":"23","author":"D Bhasin","year":"2013","unstructured":"Bhasin, D., Etter, J. P., Chettiar, S. N., Mok, M. & Li, P. K. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones. Bioorg. Med. Chem. Lett. 23, 6864\u20136867 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"35352_CR38","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1111\/jcmm.16821","volume":"25","author":"H Ying","year":"2021","unstructured":"Ying, H. et al. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-\u03b21\/Smad3 pathway. J. Cell. Mol. Med. 25, 8662\u20138675 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"35352_CR39","doi-asserted-by":"publisher","first-page":"e2101661","DOI":"10.1002\/adhm.202101661","volume":"11","author":"X Pan","year":"2022","unstructured":"Pan, X. et al. Long-Term recruitment of endogenous M2 macrophages by platelet Lysate-Rich plasma macroporous hydrogel scaffold for articular cartilage defect repair. Adv. Healthc. Mater. 11, e2101661 (2022).","journal-title":"Adv. Healthc. Mater."},{"key":"35352_CR40","doi-asserted-by":"publisher","first-page":"e16206","DOI":"10.1016\/j.heliyon.2023.e16206","volume":"9","author":"M Hu","year":"2023","unstructured":"Hu, M. et al. M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects. Heliyon 9, e16206 (2023).","journal-title":"Heliyon"},{"key":"35352_CR41","doi-asserted-by":"publisher","first-page":"eabo0987","DOI":"10.1126\/sciadv.abo0987","volume":"8","author":"S Gao","year":"2022","unstructured":"Gao, S. et al. PKM2 promotes pulmonary fibrosis by stabilizing TGF-\u03b21 receptor I and enhancing TGF-\u03b21 signaling. Sci. Adv. 8, eabo0987 (2022).","journal-title":"Sci. Adv."},{"key":"35352_CR42","doi-asserted-by":"publisher","first-page":"e13299","DOI":"10.1111\/cpr.13299","volume":"55","author":"D Li","year":"2022","unstructured":"Li, D. et al. TGF-\u03b21 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages. Cell Prolif. 55, e13299 (2022).","journal-title":"Cell Prolif."},{"key":"35352_CR43","doi-asserted-by":"publisher","first-page":"e2412123","DOI":"10.1002\/advs.202412123","volume":"12","author":"Q Yao","year":"2025","unstructured":"Yao, Q. et al. METTL3 potentiates M2 Macrophage-Driven MMT to aggravate renal allograft fibrosis via the TGF-\u03b21\/Smad3 Pathway. Adv. Sci. 12, e2412123 (2025).","journal-title":"Adv. Sci."},{"key":"35352_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/iovs.61.2.19","volume":"61","author":"J Baek","year":"2020","unstructured":"Baek, J. et al. Elevated M2 macrophage markers in epiretinal membranes with ectopic inner foveal layers. Investig. Ophthalmol. Vis. Sci. 61, 19 (2020).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"35352_CR45","doi-asserted-by":"crossref","unstructured":"Helissey, C. et al. Chronic inflammation and radiation-induced cystitis: molecular background and therapeutic perspectives. Cells 10, (2020).","DOI":"10.3390\/cells10010021"},{"key":"35352_CR46","doi-asserted-by":"crossref","unstructured":"Wan, H. Q. et al. GPR40 activation alleviates pulmonary fibrosis by repressing M2 macrophage polarization through the PKD1\/CD36\/TGF-\u03b21 pathway. Acta Pharmacol. Sinica, (2025).","DOI":"10.1038\/s41401-025-01558-y"},{"key":"35352_CR47","doi-asserted-by":"publisher","first-page":"117768","DOI":"10.1016\/j.ejmech.2025.117768","volume":"294","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Discovery of potent anti-idiopathic pulmonary fibrosis (IPF) agents based on an o-aminopyridinyl alkynyl scaffold. Eur. J. Med. Chem. 294, 117768 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"35352_CR48","doi-asserted-by":"publisher","first-page":"113862","DOI":"10.1016\/j.jconrel.2025.113862","volume":"383","author":"S Zheng","year":"2025","unstructured":"Zheng, S. et al. M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN SiRNA delivery and idiopathic pulmonary fibrosis therapy. J. Controlled Release: Official J. Controlled Release Soc. 383, 113862 (2025).","journal-title":"J. Controlled Release: Official J. Controlled Release Soc."},{"key":"35352_CR49","doi-asserted-by":"crossref","unstructured":"Li, S. et al. Targeting Lp-PLA2 inhibits profibrotic monocyte-derived macrophages in silicosis through restoring cardiolipin-mediated mitophagy. Cellular Mol. Immunol. (2025).","DOI":"10.1038\/s41423-025-01288-5"},{"key":"35352_CR50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/labinvest.2013.108","volume":"93","author":"X Song","year":"2013","unstructured":"Song, X. et al. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-\u03b21\/Smad3 signaling pathway in rats. Lab. Invest. 93, 1219\u20131231 (2013).","journal-title":"Lab. Invest."},{"key":"35352_CR51","doi-asserted-by":"publisher","first-page":"117414","DOI":"10.1016\/j.taap.2025.117414","volume":"501","author":"M Elshal","year":"2025","unstructured":"Elshal, M. et al. 3,4-Dimethoxycinnamic acid from coffee Silverskin Biowaste ameliorates bleomycin-induced pulmonary fibrosis via modulating caveolin-1-dependent activation of NF-\u03baB, TGF-\u03b21\/Smad3, and ERK1\/2 signaling pathways. Toxicol. Appl. Pharmcol. 501, 117414 (2025).","journal-title":"Toxicol. Appl. Pharmcol."},{"key":"35352_CR52","doi-asserted-by":"publisher","first-page":"175184","DOI":"10.1016\/j.ejphar.2022.175184","volume":"931","author":"Y Rui","year":"2022","unstructured":"Rui, Y. et al. Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization. Eur. J. Pharmacol. 931, 175184 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"35352_CR53","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41418-020-00650-6","volume":"28","author":"LZ Rao","year":"2021","unstructured":"Rao, L. Z. et al. IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell. Death Differ. 28, 1270\u20131283 (2021).","journal-title":"Cell. Death Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35352-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:02:41Z","timestamp":1770242561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35352-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35352"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35352-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4864"}}